Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy

Frontiers in Genetics

Volumn 5, Issue NOV, 2014, Pages

  Ishikawa, Toshihisa ^a,b  

^a Personalized Medicine Research Institute NGO Personalized Medicine and Healthcare   (Japan)

^b RIKEN   (Japan)

Author keywords

ABCG2; Anti oxidant response element (ARE); Drug resistance; NRF2; Single nucleotide polymorphism (SNP)

Indexed keywords

ABC TRANSPORTER; GLUTATHIONE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2;

ALLELE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SPECIFIC SURVIVAL; CELL PROLIFERATION; DRUG RESISTANCE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; LUNG CANCER; OVERALL SURVIVAL; OXIDATIVE STRESS; PHENOTYPE; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TRANSCRIPTION INITIATION;

EID: 84917670738     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00383     Document Type: Short Survey

References (36)

1. Adachi, T., Nakagawa, H., Chung, I., Hagiya, Y., Hoshijima, K., Noguchi, N., et al. (2007). Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J. Exp. Ther. Oncol. 6, 335-648.
2. Cho, H. Y., Reddy, S. P., DeBiase, A., Yamamoto, M., and Kleeberger, S. R. (2005). Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med. 38, 325-343. doi: 10.1016/j.freeradbiomed.2004.10.013
3. Gomi, A., Shinoda, S., Masuzawa, T., Ishikawa, T., and Kuo, M. T. (1997). Transient induction of the MRP/GS-X pump and γ-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea in human glioma cells. Cancer Res. 57, 5292-5299.
4. Hayes, J. D., and McMahon, M. (2009). NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 34, 176-188. doi: 10.1016/j.tibs.2008.12.008
5. Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., et al. (2009). Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 15, 3423-3432. doi: 10.1158/1078-0432.CCR-08-2822
6. Huang, W. C., Chen, Y. J., Li, L. Y., Wei, Y. L., Hsu, S. C., Tsai, S. L., et al. (2011). Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells. J. Biol. Chem. 286, 20558-20568. doi: 10.1074/jbc.M111.240796
7. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., et al. (2000). Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275, 16023-16029. doi: 10.1074/jbc.275.21.16023
8. Ishikawa, T., Bao, J. J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., et al. (1996). Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271, 14981-14988. doi: 10.1074/jbc.271.25.14981
9. Ishikawa, T., and Hayashizaki, Y. (2013). Clinical SNP detection by SmartAmp method. Methods Mol. Biol. 1015, 55-69. doi: 10.1007/978-1-62703-435-7_3
10. Itoh, K., Igarashi, K., Hayashi, N., Nishizawa, M., and Yamamoto, M. (1995). Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell. Biol. 15, 4184-4193.
11. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, Y., Igarashi, K., Engel, J. D., et al. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86. doi: 10.1101/gad.13.1.76
12. Kobayashi, M., and Yamamoto, M. (2006). Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46, 113-140. doi: 10.1016/j.advenzreg.2006.01.007
13. Kuo, M. T., Bao, J. J., Curley, S. A., Ikeguchi, M., Johnston, D. A., and Ishikawa, T. (1996). Frequent coordinated over0expression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res. 56, 3642-3644.
14. Kuo, M. T., Bao, J., Furuichi, M., Yamane, Y., Gomi, A., Savaraj, N., et al. (1998). Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. Biochem. Pharmacol. 55, 605-615. doi: 10.1016/S0006-2952(97)00494-2
15. Kwak, M. K., Itoh, K., Yamamoto, M., and Kensler, T. W. (2002). Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol. Cell. Biol. 22, 2883-2892. doi: 10.1128/MCB.22.9.2883-2892.2002
16. Lau, A., Villeneuve, N. F., Sun, Z., Wong, P. K., and Zhang, D. D. (2008). Dual roles of Nrf2 in cancer. Pharmacol. Res. 58, 262-270. doi: 10.1016/j.phrs.2008.09.003
17. Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlica, A. E., Vuong, H., Lanken, P. N., et al. (2007). Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 21, 2237-2246. doi: 10.1096/fj.06-7759com
18. Meyer zu Schwabedissen, H. E., Grube, M., Dreisbach, A., Jedlitschky, G., Meissner, K., Linnemann, K., et al. (2006). Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab. Dispos. 34, 524-533. doi: 10.1124/dmd.105.007591
19. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., et al. (2012). Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79. doi: 10.1016/j.ccr.2012.05.016
20. Moi, P., Chan, K., Asunis, I., Cao, A., and Kan, Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 91, 9926-9930. doi: 10.1073/pnas.91.21.9926
21. Motohashi, H., and Yamamoto, M. (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557. doi: 10.1016/j.molmed.2004.09.003
22. Nguyen, T., Nioi, P., and Pickett, C. B. (2009). The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol. Chem. 284, 13291-13295. doi: 10.1074/jbc.R900010200
23. Okano, Y., Nezu, U., Enokida, Y., Lee, M. T. M., Kinoshita, H., Lezhava, A., et al. (2013). SNP (-617C > A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women. PLoS ONE 8:e73794. doi: 10.1371/journal.pone.0073794
24. Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., et al. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98, 3410-3415. doi: 10.1073/pnas.051618798
25. Saito, H., Hirano, H., Nakagawa, H., Fukami, T., Oosumi, K., Murakami, K., et al. (2006). A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions. J. Pharmacol. Exp. Ther. 317, 1114-1124. doi: 10.1124/jpet.105.099036
26. Shelton, P., and Jaiswal, A. K. (2013). The transcriptional factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J. 27, 414-423. doi: 10.1096/fj.12-217257
27. Shen, G., and Kong, A. N. (2009). Nrf2 plays an important role in coordinated regulation of phase II drug metabolism enzymes and phase III drug transporters. Biopharm. Drug Dispos. 30, 345-355. doi: 10.1002/bdd.680
28. Singh, A., Wu, H., Zhang, P., Happel, C., Ma, J., and Biswal, S. (2010). Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol. Cancer Ther. 9, 2365-2376. doi: 10.1158/1535-7163.MCT-10-0108
29. Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274. doi: 10.1126/science.1133427
30. Solis, L. M., Behrens, C., Dong, W., Suraokar, M., Ozburn, N. C., Moran, C. A., et al. (2010). Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin. Cancer Res. 16, 3743-3753. doi: 10.1158/1078-0432.CCR-09-3352
31. Sporn, M. B., and Liby, K. T. (2012). NRF2 and cancer: the good, the bad and the importance of context. Nat. Rev. Cancer 12, 564-571. doi: 10.1038/nrc3278
32. Taguchi, K., Motohashi, H., and Yamamoto, M. (2011). Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140. doi: 10.1111/j.1365-2443.2010.01473.x
33. Yamadori, T., Ishii, Y., Homma, S., Morishima, Y., Kurishima, K., Itoh, K., et al. (2012). Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene 31, 4768-4777. doi: 10.1038/onc.2011.628
34. Yamamoto, T., Yoh, K., Kobayashi, A., Ishii, Y., Kure, S., Koyama, A., et al. (2004). Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem. Biophys. Res. Commun. 321, 72-79. doi: 10.1016/j.bbrc.2004.06.112
35. Yamane, Y., Furuichi, M., Song, R., Van, N. T., Mulcahy, R. T., Ishikawa, T., et al. (1998). Expression of multidrug resistance protein/GS-X pump and γ-glutamylcysteine synthetase genes is regulated by oxidative stress. J. Biol. Chem. 273, 31075-31085. doi: 10.1074/jbc.273.47.31075
36. Yoo, N. J., Kim, H. R., Kim, Y. R., An, C. H., and Lee, S. H. (2012). Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60, 943-952. doi: 10.1111/j.1365-2559.2012.04178.x